1. Home
  2. |Insights
  3. |Attention Security Managers and FSOs

Attention Security Managers and FSOs

Client Alert | 1 min read | 07.05.17

The Office of the Director of National Intelligence has issued Security Executive Agency Directive 3, and increased reporting requirements for executive branch employees and contractors with access to classified information or who hold sensitive positions. Among other things, covered individuals must report non-work related foreign travel to their local security office for advance approval and security briefing, and any unplanned day trips into Mexico or Canada must be reported within five days of returning to the U.S. Additionally, the directive requires that all individuals with access to classified information report any continuing association with foreign nationals with whom they share “affection, personal obligation or intimate contact,” as well as any contact with foreign nationals that results in the sharing of personal information.

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...